Incannex Healthcare (IXHL) Net Margin (2024)
Incannex Healthcare's (IXHL) quarterly Net Margin came in at 49116.67% in Q4 2024, down 570.6% quarter-over-quarter from 7324.32% in Q3 2024.
Incannex Healthcare (IXHL) Net Margin (2024) Analysis & Trends
Incannex Healthcare has disclosed Net Margin across 1 years of filings, most recently posting 49116.67% for Q4 2024.
- Net Margin for Q4 2024 came in at 49116.67%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was 54517.44% (changed N/A YoY), and the FY2025 annual result was 54517.44%, up 9930756.0% from the prior year.
- Net Margin came in at 49116.67% for Q4 2024 at Incannex Healthcare, down from 7324.32% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 7324.32% in Q3 2024 to a low of 49116.67% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -49,116.67% |
| Sep 30, 2024 | -7,324.32% |